TIANYIN PHARMACEUTICAL CO IN COM - 88630M104
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| POPE ASSET MANAGEMENT, LLC | History | Reduced | 2,284,900 | 2,244 | 1.29% | 5.65% | 1 | -2,872,758 | -55.7% | Q1 2014 | May 09, 2014 |
| RENAISSANCE TECHNOLOGIES LLC | History | Added to | 620,100 | 609 | 0.0% | 0.0% | 2 | +131,400 | 26.89% | Q1 2014 | May 14, 2014 |
| KCG Holdings, Inc. | History | Reduced | 40,039 | 39 | 0.0% | 0.0% | 3 | -4,858 | -10.82% | Q1 2014 | May 15, 2014 |
| CITADEL ADVISORS LLC | History | Added to | 39,092 | 38 | 0.0% | 0.0% | 4 | +24,289 | 164.08% | Q1 2014 | May 15, 2014 |
| Rotella Capital Management, Inc. | History | New | 30,305 | 30 | 0.04% | — | 5 | +30,305 | New | Q1 2014 | May 21, 2014 |
| Spark Investment Management LLC | History | Reduced | 25,900 | 25 | 0.0% | 0.01% | 6 | -14,800 | -36.36% | Q1 2014 | May 13, 2014 |
| Regent Investment Management LLC | History | No change | 24,600 | 24 | 0.01% | 0.01% | 7 | 0 | 0.0% | Q1 2014 | Apr 14, 2014 |
| CREDIT SUISSE AG/ | History | New | 15,343 | 15 | 0.0% | — | 8 | +15,343 | New | Q1 2014 | May 15, 2014 |
| Baltimore-Washington Financial Advisors, Inc. | History | No change | 5,100 | 5 | 0.0% | 0.0% | 9 | 0 | 0.0% | Q1 2014 | May 01, 2014 |
| UBS AG | History | Closed out | 0 | 0 | — | 0.0% | — | -3,088 | -100.0% | Q1 2014 | May 16, 2014 |